Rectal Indomethacin to Prevent Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether peri-procedural administration of rectal
indomethacin, compared to placebo, can reduce the incidence of post-ERCP pancreatitis.